Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2024-05-03 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the date of the upcoming Board Meeting scheduled for 14th May 2024. The agenda includes consideration and approval of audited financial results for the quarter and financial year ended 31st March 2024, and consideration of dividend recommendation. It also mentions the closure of the trading window for insiders. The document is an announcement of the date and agenda of a Board Meeting, not the actual financial results or report itself. The document length is short (2511 characters) and it serves as an intimation rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification to exchanges about board meeting and trading window closure, rather than a full Annual Report, Earnings Release, or Board/Management Information about changes in directors.
2024-05-03 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the voting results and scrutinizer's report on a postal ballot conducted by Themis Medicare Limited. It includes detailed voting results, the scrutinizer's report, references to the Companies Act, SEBI regulations, and the postal ballot notice date. The content focuses on the outcome of shareholder voting on a resolution related to material related party transactions. There is no financial data or earnings information, nor is it a report publication announcement. The document is clearly an official announcement of voting results and the scrutinizer's report, fitting the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data and the scrutinizer's report, not just a brief notice or certification. Therefore, the appropriate classification is DVA with high confidence.
2024-04-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2024. It is issued by the Registrar and Share Transfer Agent confirming dematerialisation of securities and related compliance. The document is addressed to stock exchanges and is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion, nor is it an announcement of voting results or capital changes. It is a regulatory compliance filing related to securities dematerialisation. The document length is short (3489 characters) and it is a certificate, so it fits best under Regulatory Filings (RNS) as a compliance document rather than a financial report or announcement.
2024-04-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the trading window closure period related to the upcoming financial results announcement for the quarter and financial year ended 31st March 2024. The document is a regulatory compliance announcement regarding insider trading restrictions and does not contain any financial data, report, or detailed financial results. It is also short (2326 characters) and serves as an official notification to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-27 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a Notice of Postal Ballot in newspapers, pursuant to SEBI Listing Regulations. It includes copies of newspaper advertisements and public notices related to tenders, auctions, and other announcements. There is no detailed financial data, management discussion, or report content. The document primarily serves as an announcement and evidence of compliance with regulatory disclosure requirements. It is not an Annual Report, Interim Report, Earnings Release, or any detailed financial or management report. The document is also not a certification or officer attestation. Given the nature of the content and the regulatory context, this document fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-03-12 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Postal Ballot and E-voting issued by Themis Medicare Limited dated 8th March 2024. It references the Companies Act, 2013, SEBI Listing Regulations, and details the procedure for remote e-voting for shareholders to approve a special resolution regarding related party transactions. The document includes the notice of the postal ballot, explanatory statements, voting instructions, and timelines for voting and result declaration. It is not a report of financial results, management discussion, or an annual/interim report. It is also not a voting results declaration but the notice initiating the voting process. The document is lengthy (15,000 characters) and contains the full notice text, not just an announcement or a brief summary. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2024-03-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.